Ownership history in Virtu Financial LLC · 15 quarters on record
This page tracks every 13F SEC filing in which Virtu Financial LLC reported a position in PROTALIX BIOTHERAPEUTICS INC (PLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 16,530 | -17,746 | -51.8% | 0.00% | $37K | $2.22 |
| 2024 Q4 | REDUCED | 34,276 | -9,112 | -21.0% | 0.00% | $64K | $1.88 |
| 2024 Q3 | REDUCED | 43,388 | -114,128 | -72.5% | 0.00% | $44K | $1.02 |
| 2024 Q1 | ADDED | 157,516 | +146,332 | +1308.4% | 0.02% | $198K | $1.26 |
| 2023 Q3 | REDUCED | 11,184 | -924 | -7.6% | 0.00% | $19K | $1.66 |
| 2023 Q2 | REDUCED | 12,108 | -16,708 | -58.0% | 0.00% | $24K | $2.00 |
| 2022 Q2 | ADDED | 28,816 | +13,617 | +89.6% | 0.00% | $31K | $1.09 |
| 2022 Q1 | REDUCED | 15,199 | -3,172 | -17.3% | 0.00% | $16K | $1.06 |
| 2021 Q4 | REDUCED | 18,371 | -9,373 | -33.8% | 0.00% | $15K | $0.83 |
| 2021 Q1 | ADDED | 27,744 | +8,265 | +42.4% | 0.01% | $124K | $4.46 |
As of 2025 Q4 — sorted by position size